• Results of the Extraordinary Shareholders’ Meeting

    Source: Nasdaq GlobeNewswire / 27 Dec 2022 11:00:00   America/Chicago

    Ghent, Belgium, Dec. 27, 2022 (GLOBE NEWSWIRE) -- -- Press release - regulated information

    Biotalys (Euronext - BTLS) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, held an extraordinary shareholders' meeting today at 11:00 a.m. CET at the Company’s seat.

    The legally required presence quorum was reached for the extraordinary shareholders’ meeting. The shareholders approved all items on the agenda of the meeting. All documents relating to the shareholders’ meeting can be consulted on the website of the Company. The minutes will be made available in due course.

    - ENDS –

    For further information, please contact

    Toon Musschoot, Head of IR & Communication
    T: +32 (0)9 274 54 00
    E: Toon.Musschoot@biotalys.com

    About Biotalys

    Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

    Attachments


Share on,